Checkpoint inhibitors and myeloma: promises, deadlocks and new directions

Ann Transl Med. 2020 Jun;8(12):777. doi: 10.21037/atm.2020.02.65.

Authors

Luca Bertamini¹, Francesca Gay¹

Affiliation

¹ Myeloma Unit, Division of Hematology, University of Torino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.

No abstract available

Publication types

Editorial
Comment